Evaluation for NCI Surgery Branch Clinical Research Protocols
About this study
Background: The National Cancer Institute Surgery Branch (NCI-SB) has developed experimental therapies that involve taking white blood cells from patients' tumor or from their blood, growing them in the laboratory in large numbers, and then giving the cells back to the patient. Objective: This study will allow patients to under screening and evaluation for participation in NC-SB Protocols. Eligibility: Patients 18 years or older must meet the minimum eligibility criteria for an NCI-SB treatment protocol. Design Patients will undergo testing and evaluations as required by the appropriate NCI-SB treatment protocol. ...
- Condition
- Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer
- Sponsor
- National Cancer Institute (NCI)
Who can join
- Age
- 18 years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
Inclusion 6
- Minimum age: 18 years
- Study condition: Synovial Cell Cancer, Melanoma, Colorectal Cancer, Lung Cancer, Bladder Cancer
- Age \>= 18 years.
- Patient suspected of having, or with biopsy proven, malignant disease.
- Patient is able to understand and willing to sign a written informed consent document.
- Patient is being evaluated for treatment on an NCI-SB protocols.
Exclusion 1
- Women of child-bearing potential who are pregnant or plan to become pregnant because of the potentially dangerous effects of some of the screening procedures (e.g., nuclear medicine or other imaging scans) on the fetus.
Where
1 site, 1 recruiting
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Contact
-
NCI SB Immunotherapy Recruitment Center
(866) 820-4505 irc@nih.gov
Potential match only. Final eligibility is determined by the study team.